XtalPi AI platform accelerates HIV 1 drug candidate selection within seven months
Technology firm XtalPi utilised artificial intelligence models to nominate a preclinical candidate targeting the MPER region of HIV 1 gp41 for portfolio company Viva Thera within seven months
We haven't written up this one. Vietnam Investment Review has the full story — the link below goes straight to it.